Residual effects of low dose of suvorexant, zolpidem, and ramelteon in healthy elderly subjects: A randomized double‐blind study

Introduction Current hypnotic agents have next‐day residual effects. The new orexin antagonist, suvorexant, has little muscle relaxation effect on the physical and cognitive function in the following morning and daytime. In this study, the effects of suvorexant, zolpidem, ramelteon and placebo in el...

Full description

Saved in:
Bibliographic Details
Published inNeuropsychopharmacology Reports Vol. 42; no. 3; pp. 288 - 298
Main Authors Uemura, Sachiko Ito, Imanishi, Aya, Terui, Yoshino, Park, Insung, Satake, Masahiro, Han, GoEun, Shioya, Takanobu, Kanbayashi, Takashi, Nishino, Seiji
Format Journal Article
LanguageEnglish
Published Hoboken Wiley 01.09.2022
John Wiley & Sons, Inc
John Wiley and Sons Inc
Subjects
Online AccessGet full text
ISSN2574-173X
2574-173X
DOI10.1002/npr2.12262

Cover

More Information
Summary:Introduction Current hypnotic agents have next‐day residual effects. The new orexin antagonist, suvorexant, has little muscle relaxation effect on the physical and cognitive function in the following morning and daytime. In this study, the effects of suvorexant, zolpidem, ramelteon and placebo in elderly subjects were evaluated. Methods Six men and eight women aged 63–75 years received a single tablet and lights were then turned off. Subjects were instructed to sleep from 23:00–6:00 with an interruption from 4:00–4:30 for evaluations. Suvorexant 10 mg, zolpidem 5 mg, ramelteon 4 mg or placebo was administered single time in a randomized, double‐blind and crossover design with a one‐week drug holiday in between each drug. Measures of objective parameters and subjective ratings were obtained every 2 h from 4:00 to 16:00. Result No subjects showed serious side effects from physical observations and vital sign checks before and after hypnotics were taken. During the first sleep period, the REM sleep time with suvorexant was especially longer than that with zolpidem. During the second sleep period, suvorexant had shorter sleep latency and longer stage2 sleep time than ramelteon and zolpidem, respectively. During the whole entire sleep, the REM sleep time with suvorexant was longer than zolpidem and placebo. For the body sway test with closed eye, the main effects of the medicines and zolpidem were significantly better than suvorexant and ramelteon. Conclusion The changes of physical and cognitive functions in healthy elderly after taking hypnotics were not remarkable. Therefore, these three hypnotics maybe appropriate for the elderly people with insomnia for single‐time low dose administration.
Bibliography:This study was supported by JSPS KAKENHI Grant‐in‐Aid for Scientific Research (C): 16 K01496 for Sachiko Uemura, AMED under Grant Number JP19dm0908001, JP20dm0107162, JP21zf0127005 and JSPS KAKENHI Grant‐in‐Aid for Scientific Research (C): 19 K08037 for Takashi Kanbayashi
Funding Information
ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ISSN:2574-173X
2574-173X
DOI:10.1002/npr2.12262